StockData
Jaguar Health, Inc. logo

Jaguar Health, Inc. (JAGX) stock

JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.39−0.03 (-7.14%)

Close on Nov 16, 2026Market cap $2.02MP/E –Yield –

Jaguar Health price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Jaguar Health

Jaguar Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Jaguar Health figures

See a number that looks wrong?